Skip to main content
. 2021 Dec 6;11:614. doi: 10.1038/s41398-021-01741-9

Fig. 1. Hypertensive and non-hypertensive molecular pathways to concentric cardiac remodelling.

Fig. 1

NAFLD non-alcoholic fatty liver disease, ALP alkaline phosphatase, GGT gamma-glutamyltransferase, hsCRP high-sensitivity C-reactive protein, LDL and HDL low- and high-density lipoprotein, HOMA-IR Homeostatic Model Assessment for Insulin Resistance, PWV pulse-wave velocity, BNP brain natriuretic peptide, ET-1 endothelin-1, SBP and DBP systolic and diastolic blood pressure. Graphic element credit: GraphicsRF/Shutterstock.com.